Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-03-17 00:00:00 ET · period of report 2022-03-15 · accession 0001567619-22-007183 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-17 | 2022-03-15 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | F - Tax | $78.27 | -920 | 52.1K | -2% | -$72.0K |
| D | 2022-03-17 | 2022-03-15 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | A - Grant | $0.00 | +11.0K | 53.0K | +26% | $0 |
| D | 2022-03-17 | 2022-03-15 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | A - Grant | $0.00 | +26.5K | 26.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-15 | F | D | 920 | $78.27 | 52,056 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-15 | A | A | 11,040 | $0.00 | 52,976 | D | — | — | (F1) Restricted stock units granted on March 15, 2022. Price not applicable. |
| 3 | Derivative | Stock Option (Right to buy Common Stock) | 2022-03-15 | A | A | 26,520 | $0.00 | 26,520 | D | $78.27 · 2023-03-15 to 2032-03-14 | 26,520 Common Stock | (F2) Option grant vests 12/48th on March 15, 2023 and 1/48th on the 15th day of each month thereafter. |